Chapter 121 Global Nephrology Summit (please subscribe)
Ten minutes later,
Zhang Yang took out 2,000 yuan from his bag and put it on the coffee table, and told Jiang Yong if the matter was handled If you still want to come to work after this is over, you can come and report at any time.
There was only so much he could do.
Of course, he can give Jiang Yong a sum of money to make Jiang Yong's life a little easier.
But can he guarantee that Zhang Yong, who is undergoing dialysis, will still be alive in ten or fifteen years?
Can he guarantee that Jiang Yong’s wife will never leave him?
And.
There are millions of uremia patients and more than one million dialysis patients in the country. Can he help them all?
Impossible.
He can't help. What he can really do is use Qingshan Pharmaceutical to find ways to truly improve the quality of life of these dialysis patients so that they can have a certain ability to earn money to support their families.
For example, the "Kidney Toxic Clear Dialysis Replacement Needle" obtained from the simulator.
"Come on, Zhang Yang."
Sighing, an hour later, he returned to Qingshan Pharmaceutical.
Perhaps because of the impact of Jiang Yong's incident, Zhang Yang immediately locked the office door and entered the simulator after returning to the office. He wanted to see if the next node of the simulator was about kidney disease.
But after entering the simulator, the next new node did not appear, so I had to exit again.
In desperation, he went to the International Society of Nephrology (ISN), a world-renowned renal academic forum, to see if there were any recent advances in dialysis technology.
Actually,
because of the "Kidney Toxic Clear Dialysis Replacement Needle" rewarded by the research system some time ago, he already has a more and deeper understanding of dialysis.
Hemodialysis started in the country about 25 years ago,
Before its appearance, the only way to suffer from uremia was kidney transplantation, commonly known as "kidney replacement." However, kidney transplantation is expensive, and where are there so many kidney sources?
Therefore, the emergence of dialysis has brought hope of life to countless uremia patients in China and extended the lives of countless people.
But hemodialysis is not without side effects, and can even be said to have serious side effects.
In daily life, normal human beings take in food and energy, and the body metabolizes and excretes it.
For example, if you eat or drink water at noon, the metabolites and toxins produced by these foods will be excreted in the urine about two hours later.
In this way, only a small amount of toxins are always present in the human body.
But dialysis patients are different!
Once uremic patients undergo dialysis, they will soon have no urine at all, and their method of removing toxins will begin to rely entirely on hemodialysis.
Usually, dialysis is performed three times a week, with an interval of two to three days between each time. In other words, all toxins and metabolic substances produced by the body will accumulate for two to three days after each dialysis. In the body until the next dialysis is completed!
Maybe a year or two will be fine in this situation,
But for ten or fifteen years, a large amount of toxins accumulate in the body almost every day and cannot be discharged. If this continues, it will inevitably have an irreversible impact on the heart, liver, blood vessels and other organs.
Especially the heart.
In two days, the human body always needs to drink water. Drinking water and not expelling it will inevitably increase the load on the heart. This is why most dialysis patients will have heart problems after five years.< br>
This is also the reason why the vast majority of dialysis patients eventually die of heart failure and myocardial infarction.
Besides,
Because dialysis patients undergo hemodialysis once a day, all dialysis patients will have "ostomy".
To put it simply, the tube used to guide blood input and output is buried in the body for a long time, so that there is no need to re-insert the needle every time for dialysis, which is similar to an "indwelling needle".
But this method of having tubes buried in the body 365 days a year can easily cause infection, and secondly...
And most importantly, it can easily cause arteriosclerosis.
In fact, these are not bad. The real biggest risk of hemodialysis is sudden hypotension.
Hemodialysis will extract human blood from the body. This method cannot avoid the reduction of blood volume and blood pressure in the body. If the patient has other complications at this time, it is easy to die directly.
This is not an alarmist statement. Countless dialysis patients die in dialysis rooms every year and cannot be rescued at all.
These are the main reasons why the current median survival period of uremic dialysis in China is 13.7 years.
Thinking about it, Zhang Yang withdrew from the "International Society of Nephrology Forum". Gradually, he also sorted out his thoughts.
Next, he will develop and market the "Kidunduqing dialysis replacement needle" provided by the system as soon as possible to provide countless dialysis patients with a better quality of life.
At the same time, we will also see if we can use the existing R&D team to develop a drug that can treat or prevent the progression of early- and mid-stage chronic nephritis on the basis of "Kenduqing dialysis replacement injection" and truly reduce uremia. patient.
After making up his mind, Zhang Yang started focusing on these two things.
But a few days later, while he was actively preparing for Qingshan Pharmaceutical's kidney disease research and development team, Ren Xiaomin suddenly put a resume in front of him.
"Zhang Yang, I have read your resume in detail, and also had an interview with Wei Tian."
"To be precise, it was not an interview, but a discussion together for a while. His ability His ideas and knowledge are beyond words. He can be called a master in the industry and can independently lead R&D projects. ”
"However, his only request is to chat with you alone."
Looking at the resume in front of him, Zhang Yang was a little surprised. Since the establishment of the "Drug Research and Development Center" of Qingshan Pharmaceutical, he has rarely participated in the research of researchers. When it comes to recruitment, Wei Tian and Ren Xiaomin are almost always in charge.
After he picked up his resume from his desk and read the two pages carefully, he understood why Ren Xiaomin handed the resume to him personally.
"Fang Hanliang, 41 years old, has a PhD in biology from the University of Cambridge in the UK. He currently works for Boehringer Ingelheim, a top German biopharmaceutical company, referred to as BI."
"Work experience: Participated in the company He is responsible for the research and development of the main chronic kidney disease treatment drug 'empagliflozin' and is currently responsible for the comprehensive research and development of another kidney disease drug code-named 'BI-690517' under BI Company."
Boehringer Ingelheim is a Fortune 500 company and the world's top kidney disease drug research and development company. Being able to lead the comprehensive research and development of a new drug in such a company is enough to prove Fang Hanliang's ability.
Just like Ren Xiaomin said, this is the kind of industry giant who can already lead his own projects.
After thinking for a few seconds, Zhang Yang nodded.
After all, although Qingshan Pharmaceutical's "Drug Research and Development Center" has been recruiting people since its establishment, it is difficult to meet top talents like Fang Hanliang.
After Zhang Yang confirmed it, Ren Xiaomin immediately started making arrangements, and the meeting time was set for the afternoon of the next day.
Time blinked and came to the afternoon of the next day. Zhang Yang received Fang Hanliang in the office very formally.
The aroma of tea overflowed, and the two of them sat on the sofa facing each other. Zhang Yang could be regarded as giving Fang Hanliang enough respect.
"Dr. Fang, I heard that you asked to have a chat with me. Now that you have seen me, what do you want to talk about?"
Zhang Yang spoke first. He did not act like a boss. Aloof, but chatting very casually like friends.
Fang Hanliang was also quite surprised at Zhang Yang's youth. He knew that Zhang Yang was not old, but he didn't expect him to be so young.
But he quickly adjusted, pushed up his glasses, and showed a trace of apology on his face:
"Mr. Zhang, I'm sorry to waste your time, but after all, job-hopping is a very important thing for me. It’s a big event in life, so I have to be cautious.”
Zhang Yang nodded slightly and motioned for Fang Hanliang to continue. Fang Hanliang's expression relaxed when he saw this, and continued:
"To tell you the truth, I do have plans to return to China in the past two years. First, my father is suffering from cirrhosis of the liver, and he wants me to return to China to accompany him. Around him, I also had this idea.”
"Secondly, the 'hepatocellular activator' developed by your company and a series of previous results are really impressive. As an insider in the pharmaceutical industry, I am very aware of the greatness of these drugs."
"So, I am relieved and willing to try to join your father-in-law. Secretary, I just want to ask you a question...Does the company currently plan to invest in research and development of kidney drugs?
If so, can you disclose the approximate amount of funds? ”
After the words fell, Zhang Yang was quite surprised by his sincere words.
He did not expect that Fang Hanliang would not take the initiative to talk about his past or his status in the industry, but would sincerely raise his own questions.
Zhang Yang can completely understand this problem.
To put it simply, after hundreds of years of development of human biopharmaceuticals, the entire pharmaceutical industry has entered a market segment. Most companies have only developed drugs for certain diseases for a hundred or two hundred years. R&D.
For example, Gilead mainly studies liver disease and AIDS.
So Gilead has attracted countless drug developers with experience in the field of liver diseases. In other words, the best developers in the field of liver diseases are all in Gilead.
After all, the company's main business is liver disease, and it is willing to invest. In addition, with a large group of colleagues who are also highly capable in the field of liver disease, the probability of producing results is greatly increased.
Is it appropriate for a PhD in pharmacology majoring in other fields, such as a researcher in nephrology, to join Gilead?
Obviously inappropriate.
Qingshan Pharmaceutical has previously made some achievements mainly in the fields of blood diseases and liver diseases. As a researcher in the field of nephrology, Fang Hanliang is indeed worried about this.
After a moment, Zhang Yang said:
"I completely understand your worries. I will answer your first question now."
"To tell you the truth, we not only plan to develop kidney disease drugs, but... we have already achieved certain results in kidney disease drugs."
Fang Hanliang was stunned:
" You...you have achieved certain results in kidney disease drugs? "
Zhang Yang didn't hide anything, nodded and said:
"Due to the company's commercial confidentiality, I can't reveal too many details to you, but I can tell you that this is a product mainly aimed at dialysis patients. , a 'toxin metabolism needle' that can temporarily replace dialysis."
"Its appearance is very likely to greatly improve the quality of life of dialysis patients."
Speaking, Zhang Yang paused:
"Now to answer your second question, currently we have The initial project R&D funding is 500 million yuan. If there are subsequent R&D results, this investment can be expanded to 1 billion or even 10 billion yuan.”
Fang Hanliang was shocked. He had no idea that Qingshan Pharmaceutical had already begun to invest in kidneys. Drug research and development has begun, and certain results have been achieved!
After a minute, he took a deep breath, nodded and said:
"Mr. Zhang, I understand, thank you."
"I have no problem."
This time, Zhang Yang was stunned for a moment.
"Aren't you going to talk about salary or benefits again?"
"No need."
Fang Hanliang smiled and shook his head.
"I have already seen the salary package you have given me, and I am very satisfied with it, so there is no need to talk about it anymore."
Speaking, Fang Hanliang stood up from the sofa:
“Okay, Mr. Zhang, I won’t bother you more. Thank you, but I hope you can give me two days to think about it finally.”
“Also, I am still an employee of BI company, and it will take me about half a year to deal with the resignation. I hope you can. Understandable.”
"Okay! I look forward to your joining."
The meeting between the two did not take too long, and this sincere communication method also made Zhang Yang have a good impression of Hanliang.
While Zhang Yang was dealing with the matter of meeting Fang Hanliang, on the other side, West China Dean Gan Weiguo was looking at an electronic invitation letter on the computer screen in a daze.
This is an invitation letter from the "International Society of Nephrology (ISN)", inviting West China Hospital to participate in this year's "Global Nephrology Summit" to be held in the Magic City of China.
The "Global Nephrology Summit" is held every two years, and will invite doctors from the world's top kidney disease hospitals, as well as the world's major kidney disease drug R&D pharmaceutical companies to participate in the event, aiming to exchange and learn the latest global trends. cutting-edge technologies and drugs for kidney disease.
There are two places to participate in the Huaxia District every year. Since Huaxi made breakthrough results in "kidney transplant matching" last year, this time it beat Southern Medical University to be on the invitation list.
At the same time, also because of the breakthrough results achieved last year, Huaxi also received a recommendation quota this time to recommend a pharmaceutical company to participate in this summit.
For pharmaceutical companies, this is naturally a very good place to promote their own kidney disease drugs, but after much thought, Gan Weiguo did not think of a suitable kidney disease manufacturer, so soon.
His thoughts fell on Qingshan Pharmaceutical.
Ever since the last time when deputy director Chen Yifei of the Hepatology Department moved to Chengdu No. 3 People's Hospital, Gan Weiguo realized that he must have a good relationship with Qingshan Pharmaceutical.
But after all the efforts, the results were not very good, and the relationship with Qingshan Pharmaceutical was still tepid.
This precious summit quota is a good way, but...
Gan Weiguo is also a little undecided:
“Qingshan Pharmaceutical mainly deals with liver diseases and blood diseases. There are research and development results in the field of nephrology and Is it appropriate to give the spot for this kidney disease summit to Zhang Yang without any good results?”
“Furthermore, will it cause him misunderstanding or dissatisfaction? After all, they are still in the field of kidney disease?” Nothing came of it.”
After struggling for half an hour, Gan Weiguo simply decided to visit Zhang Yang in person to find out what Zhang Yang was saying.
If Qingshan Pharmaceutical is interested, I will take advantage of the situation and offer this place. If not, just try to get closer to Zhang Yang.
Ten minutes later, under the attention of the security guards, he drove slowly out of West China and came to Qingshan Pharmaceutical.
The team leader, Luo, was standing guard today. When he saw a car with an unfamiliar license plate parked in front of the access control at the gate of Qingshan Pharmaceutical, he held the registration form in one hand and lightly tapped the car window with the other.
“Master, please register, who are you coming to see for what reason?”
Gan Weiguo glanced at Lao Luo, and then said slowly:
"I am Gan Weiguo, the president of West China Hospital, and I am here to visit Mr. Zhang Yang."
Lao Luo was stunned for a moment. Even the words were stuttering.
"You...you are the dean of West China?!"
"You are here to visit our Mr. Zhang?"
......
PS: Thanks to Smiling Face Fengda for the 100-coin reward
Thanks to Wanxing Mingxin for the 500-coin reward
Thanks to Majiahezi for the 5,000-coin reward reward!
I had something to do today and I couldn’t write anything. I will continue to update from tomorrow!
(End of this chapter)